申请人:Maruishi Pharmaceutical Co., Ltd.
公开号:EP1380575A1
公开(公告)日:2004-01-14
The present invention relates to substituted 1,4-dihydro-4-oxoquinolines having antiviral activity. The substituents are present at positions 1, 2 and at least one of 5-8 positions of the quinoline ring.
本发明涉及具有抗病毒活性的取代1,4-二氢-4-氧喹啉。取代基出现在喹啉环的1、2位置和至少5-8位置之一。